{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:55:04Z","timestamp":1789815304778,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.arcped.2005.10.020","type":"journal-article","created":{"date-parts":[[2005,12,19]],"date-time":"2005-12-19T15:52:07Z","timestamp":1135007527000},"page":"175-180","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacovigilance des\u00a0vaccins"],"prefix":"10.1016","volume":"13","author":[{"given":"E.","family":"Autret-Leca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bensouda-Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Jonville-B\u00e9ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Beau-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2005.10.020_bib1","unstructured":"D\u00e9cret du 24 mai 1984 (JO du 30\/5\/1984) Livre V du Code de la Sant\u00e9 publique (articles R5144-1 et R5144-11). D\u00e9cret 95\/278 du 13 mars 1995. D\u00e9cret 95-566 du 6 mai 1995."},{"key":"10.1016\/j.arcped.2005.10.020_bib2","first-page":"439","article-title":"M\u00e9thodologie d'\u00e9valuation des vaccins viraux","volume":"51","author":"Aymard","year":"1996","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.arcped.2005.10.020_bib3","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments","volume":"40","author":"Begaud","year":"1985","journal-title":"Th\u00e9rapie"},{"key":"10.1016\/j.arcped.2005.10.020_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMra010462","article-title":"The prevention of pneumococcal disease in children","volume":"345","author":"Giebink","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM200110183451612","article-title":"Pneumococcal research transformed","volume":"345","author":"Musser","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0399-077X(03)00181-1","article-title":"Tol\u00e9rance des vaccins\u00a0: faits et sp\u00e9culations","volume":"33","author":"Soubeyrand","year":"2003","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.arcped.2005.10.020_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/(SICI)1099-1557(199601)5:1<33::AID-PDS210>3.0.CO;2-7","article-title":"Aseptic meningitis following mumps vaccine. A retrospective survey by the French Regional Pharmacovigilance Centres and by the firm Pasteur M\u00e9rieux S\u00e9rums et Vaccins","volume":"5","author":"Jonville-B\u00e9ra","year":"1996","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.arcped.2005.10.020_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006454-199601000-00010","article-title":"Thrombocytopenic purpura following measles, mumps and rubella vaccination","volume":"15","author":"Jonville-B\u00e9ra","year":"1996","journal-title":"Pediatr. Infec. Dis. J."},{"key":"10.1016\/j.arcped.2005.10.020_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2125.2001.00341.x","article-title":"Sudden unexpected death in infants under 3\u00a0months of age and vaccination status \u2013\u2013\u00a0a case-control study","volume":"51","author":"Jonville-B\u00e9ra","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.arcped.2005.10.020_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/bmj.322.7290.822","article-title":"The UK accelerated immunisation programme and sudden unexpected death in infancy: case-control study","volume":"322","author":"Fleming","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/bmj.319.7217.1133","article-title":"Association between type 1 diabetes and Hib vaccine. Causal relation is likely","volume":"319","author":"Classen","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/bmj.319.7217.1133","article-title":"Association between type 1 diabetes and Hib vaccine. More research is still needed","volume":"319","author":"White","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.318.7192.1169","article-title":"Association between type 1 diabetes and haemophilus influenzae type b vaccination: birth cohort study","volume":"318","author":"Karvonen","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib15","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJM200106073442313","article-title":"Vaccinations and multiple sclerosis","volume":"344","author":"Begaud","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccinations and the risk of relapse in multiple sclerosis","volume":"344","author":"Confavreux","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","article-title":"Recombinant hepatitis B vaccine and the risk of multiple sclerosis","volume":"63","author":"Hernan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arcped.2005.10.020_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(95)90816-1","article-title":"Is measles vaccination a risk factor for inflammatory bowel disease?","volume":"345","author":"Thompson","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib19","first-page":"750","article-title":"Ileal-lymphoid-nodular hyperplasia, non specific colitis, and pervasive developmental disorder in children","volume":"363","author":"Wakefield","year":"2004","journal-title":"Retractation in Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/mp.55.2.84","article-title":"Potential viral pathogenic mechanism for new variant inflammatory bowel disease","volume":"55","author":"Uhlmann","year":"2002","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.arcped.2005.10.020_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/bmj.316.7146.1745","article-title":"Measles, measles vaccination, and Crohn\u2019s disease Crohn's disease has not increased in Finland","volume":"316","author":"Pebody","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(98)24018-9","article-title":"No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study","volume":"351","author":"Peltola","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib23","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1136\/bmj.316.7146.1745","article-title":"Measles, measles vaccination, and Crohn\u2019s disease. Second immunisation has not affected incidence in England","volume":"316","author":"Miller","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.322.7284.460","article-title":"Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis","volume":"322","author":"Kaye","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.324.7334.393","article-title":"Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study","volume":"324","author":"Taylor","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jama.285.9.1183","article-title":"Time trends in autism and in MMR immunization coverage in California","volume":"285","author":"Dales","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2005.10.020_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0140-6736(97)03192-9","article-title":"A case-control study of measles vaccination and inflammatory bowel disease","volume":"350","author":"Feeney","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1001\/jama.284.18.2307","article-title":"Vaccines pose no diabetes, bowel disease risk","volume":"284","author":"Stephenson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2005.10.020_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archpedi.155.3.354","article-title":"Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease","volume":"155","author":"Davis","year":"2001","journal-title":"Arch. Pedriatr. Adolesc. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa021134","article-title":"A population-based study of measles, mumps, and rubella vaccination and autism","volume":"347","author":"Madsen","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib31","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0264-410X(02)00770-3","article-title":"Systematic review of the effects of pertussis vaccines in children","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.arcped.2005.10.020_bib32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(00)02866-X","article-title":"Time to review policy on contraindications to vaccination","volume":"356","author":"Ramsay","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib33","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/bmj.316.7135.902","article-title":"Rate of recurrent collapse after vaccination with whole cell pertussis vaccine: follow up study","volume":"316","author":"Vermeer-de Bondt","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib34","first-page":"83","article-title":"Severe adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle\/Takeda accellular pertussis component DTP (DtaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine","volume":"89","author":"Uberall","year":"1997","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.arcped.2005.10.020_bib35","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","article-title":"Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT","volume":"112","author":"Le Saux","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.arcped.2005.10.020_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bmj.38045.858889.EB","article-title":"Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study","volume":"328","author":"Maitra","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.arcped.2005.10.020_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures. Evaluation of susceptible subgroups and long-term prognosis","volume":"292","author":"Vestergaard","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2005.10.020_bib38","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMoa003077","article-title":"The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine","volume":"345","author":"Barlow","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arcped.2005.10.020_bib39","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1086\/379665","article-title":"Epidemiology of acute otitis media caused by streptococcus pneumoniae before and after licensure of the 7-valent pneumococcal protein conjugate vaccine","volume":"188","author":"McEllistrem","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.arcped.2005.10.020_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(98)02326-5","article-title":"Macrophagic myofasciitis: an emerging entity","volume":"352","author":"Gherardi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2005.10.020_bib41","first-page":"162","article-title":"Myofasciite \u00e0 macrophages et hydroxyde d'aluminium: vers la d\u00e9finition d'un syndrome des adjuvants","volume":"159","author":"Gherardi","year":"2003","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.arcped.2005.10.020_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.arcped.2004.06.017","article-title":"Les adjuvants vaccinaux et la myofasciite \u00e0 macrophages","volume":"12","author":"Siegrist","year":"2005","journal-title":"Arch. Ped."},{"key":"10.1016\/j.arcped.2005.10.020_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","article-title":"Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence","volume":"4","author":"Jefferson","year":"2004","journal-title":"Lancet Infect. Dis."}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X05005956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X05005956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T10:44:04Z","timestamp":1554979444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X05005956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0929693X05005956"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2005.10.020","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}